Conventional Vaccines 

MVP Laboratories provides the animal industry with conventional biologicals that are fully-licensed and manufactured in our state-of-the-art Omaha, Nebraska production facility.

These products come from herd-specific (autogenous) origins and therefore have the additional value of being from highly infectious disease outbreaks.

These products are provided in response to customer needs to have 'off-the-shelf' products available through practicing veterinarians. Additionally, the products are sold through other biological companies via private-label agreements.

MVP Laboratories currently markets two products under our own label through practicing veterinarians:

Bordetella Bronchiseptica Vaccine (avirulent live culture)

This vaccine offers effective, safe and effective atrophic rhinitis prevention in baby pigs.

  • Single dose protection
  • Contains avirulent live cultures of avirulent Bordetella bronchiseptica which colonize and block the adherence of disease-causing strains
  • Back passage studies indicate no reversion to virulence
  • Conveniently delivered intranasally via 0.5 mL in each nostril
  • Effective in the face of antibiotic therapy or maternal antibodies

Bordetella Bronchiseptica Vaccine is available in 30 mL (30-dose) and 100 mL (100-dose) plastic vials.

Emulsibac® APP (Actinobacillus pleuropneumoniae)

Rolex oyster perpetual replica Clasp on this watch is without leaving any traces. Because after wearing the bracelet perfectly. Advantage of this design is that we think of him as a watch, is more like a bracelet Perry www.myiwatch.de. For connection with the bracelet more perfect, watches as the lugs make the perfect arc, provides good protection for wrist and wears very comfortable.

Following extensive research and field trial efforts through herd-specific vaccines, Emulsibac® APP was formulated to provide outstanding protection against the most common and virulent serotypes 1, 5 and 7.

  • For prevention of pneumonia in pigs 4 weeks of age or older by infection with the prevalent serotypes of Actinobacillus pleuropneumoniae

  • Product produced through customized culture media and growth conditions that greatly enhance immunogen production and expression of all important soluble toxins
  • Adjuvanted with Emulsigen® to provide amplification of the immune response without injection site reactions
  • Equally effective via SQ or IM routes of administration
  • Controlled studies demonstrated:
  • Significant reduction in clinical signs
  • Significant reduction in body temperatures
  • Significant increase in weight gains

Emulsibac® APP is available in 50-dose (100 mL) and 125-dose (250 mL) plastic vials.

home video